Title: Study of Serum Calcium, Microalbuminuria, Urinary Calcium/Creatinine Ratio in Postmenopausal Women

Authors: Dr Rita Rani Sahu, Dr Madhusmita Acharya, Dr M. K. Mandal, Dr Jyotindra Kumar Sahu

 DOI:  https://dx.doi.org/10.18535/jmscr/v5i3.162

Abstract

Deficiency of estrogen increases generation and deposition of extracellular protein which causes glomerular injury. Microalbuminuria is a reflection of vascular damage and marker of early arterial disease in normal healthy individuals without diabetes and hypertension. Calcium/creatinine ratio is a well defined marker indicating the rate of bone resorption and duration of menopause. Aim of the study is to find out the presence of microalbuminuria and estimation of serum calcium and calcium/creatinine ratio are compared to that of controls. The study was conducted by taking 50 no of cases and 50 no controls. Cases include non diabetes and non hypertensive post menopausal women of 45 to 60 yr age group without taking vit D, calcium and hormone replacement therapy. Controls were of normal premenopausal women of 35 to 45 yr age group. The study showed that urinary microalbumin and urinary calcium/ creatinine ratio was significantly increasd in cases as compared to that of controls showing p<0.05. serum calcium level was significantly decreased(p<0.005) in cases which are found to be stastistically significant. Serum calcium level showed a negetive correlation with age and serum creatinine showed a negative correlation with urinary creatinine  The study shows that microalbuminuria is an early indicator of subclinical organ damage. Serum calcium and ca/cr ratio can be used an early marker of bone resorption in postmenopausal women. So the above parameters can be used as screening method for detection of high risk groups who are prone to further cardiovascular disease and osteoporosis. So that early intervention can be done.

Keywords: Microalbumin (MA), Calcium/Creatinine ratio(ca/cr).

References

1.      Kanis JA, Delmas P, Burckhardt P, Cooper C, Torgerson D. Guidelines for diagnosis and management of osteoporosis. The European Foundation for Osteoporosis and Bone Disease. Osteoporos Int. 1997;7 (4):390–406.

2.      Parker SE, Troisi R, Wise LA, et al. Menarche, menopause, years of menstruation, and the incidence of osteoporosis: the influence of prenatal exposure to diethylstilbestrol. J Clin Endocrinol Metab. 2014;99(2):594–601.

3.      Unni J, Garg R, Pawar R. Bone mineral density in women above 40 years. J Midlife Health. 2010;1(1):19–22.

4.      Babu AS, Ikbal FM, Noone MS, Joseph AN, Samuel P. Osteoporosis and osteopenia in India: a few more observations. Indian J Med Sci. 2009;63(2):76–77.

5.      Marwaha RK, Tandon N, Garg MK, et al. Bone health in healthy Indian population aged 50 years and above. Osteoporos Int. 2011;22(11):2829–2836.

6.      Seibel JM , Biochemical marker  of bone turnover  partI .biochemistry  and variability. ClinBiochem Rev 2005; 26(4): 97- 122

7.      Thomakos  N, Liakakos  T. Diagnostic  methods  in  osteoporosis. Arch Hellenic  Med 2000; 17(2)  146-51

8.      Calvo MS, Eyre  DR. Gundberg  CM  Molecular  basis  and  clinical  application of biological  marker  of bone turnover. Endoc, Rev  1996  17(4): 333-68

9.      Gowen M, Wood DD, Ihric EJ, MKB, Russell RGG. An interleukin -1 like  factor stimulates bone resorption in vitro, Nature 1983: 306,378-380.

10.  HansteinB, LiuHYancisinM, BrownM (1999) Functional analysis of a novel estrogen receptor-β isoform. Mol Endocrinol13:129137.

11.  Katzenellenbogen JA, Katzenellenbogen BS (1996) :Nuclear hormone receptors: ligand-activated regulators of transcription and diverse cell responses. Chem Biol3:529536

12.  KrausWL, KadonagaJT (1998) P300 and estrogen receptor cooperatively activate transcription via differential enhancement of initiation and reinitiation. Genes Dev 12:331342.

13.  Guideline LMP .Microalbuminuria (sep2, 2012) Available from http//saantana 0612 . Files wordpress.com /2009/09/microalbi-npdf

14.  Bharadwaj JA, Kendurkar  SM, Vaidya PR : Age and symptomatology of menopause in indian women. J Postgrad Med 1983; 29: 218

15.  India –based  institute for social and economic  Change, London”s  Times reports, 28 January 2007 14:08

16.  N. M Hidayet, S.A. Sharaf , S.R. Aref, T.A. Tawfic and I.I. Moubarak : Eastern Mediterranean Health Journal ,Vol 5 , Issue 2, 1999, p 307-319

17.  The  effect of age on cardiovascular risk factors in Chinese women International Journal of Cardiology ,volume 61, issue 3, pages 221- 227

18.  Ribot  C, Tremollieres  F, Pouilles JM , Louvet  JP. Guiraud  R. Influence of the menopause and aging on spinal density in French women . Bone miner 1988: 5:89-

19.  Roset  M, van der  Schouw  YT, Tempelman  MJ, et al : The factor  V Arg 506 Gln mutation is not associated  with cardiovascular mortality in older women. Am J Epidemioal. 1999:149:665-670.

20.  Lindsay R, Hart DM, Clark DM. The minimum effective dose of estrogen for postmenopausal bone loss. Obstet Gynecol 1984;63:759-763.

Corresponding Author

Dr Rita Rani Sahu

Assistant Surgeon, Department of Biochemistry

VIMSAR, Burla, Sambalpur, Odisha, 768017